Results 11 to 20 of about 3,842 (144)

The Stalk and 1B Domains Are Required for Porcine Deltacoronavirus Helicase NSP13 to Separate the Double-Stranded Nucleic Acids, and the Deletion of the ZBD Impairs This Activity [PDF]

open access: yesAnimals
The nonstructural protein 13 (NSP13) of PDCoV is a highly conservative helicase and plays key roles in viral replication. NSP13 contains a zinc-binding domain (ZBD), a helical Stalk domain, a beta-barrel 1B domain, and a core helicase domain.
Chengcheng Wu   +4 more
doaj   +2 more sources

A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance

open access: yesmBio, 2023
Coronaviruses (CoVs) encode nonstructural proteins 1–16 (nsps 1–16) which form replicase complexes that mediate viral RNA synthesis. Remdesivir (RDV) is an adenosine nucleoside analog antiviral that inhibits CoV RNA synthesis.
Samantha L. Grimes   +12 more
doaj   +3 more sources

Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties [PDF]

open access: yesCell Death Discovery
SARS-CoV-2 RNA contains guanine-rich sequences that form secondary structures known as G quadruplexes (G4s). The SARS-CoV-2 nonstructural protein (NSP13) resolves G4s due to its helicase and ATPase activity, a process essential for viral replication ...
Denisa Bojkova   +15 more
doaj   +2 more sources

Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays

open access: yesSLAS Discovery
SARS-CoV-2 nsp13 helicase is an essential enzyme for viral replication and a promising target for antiviral drug development. This study compares the double-stranded RNA (dsRNA) unwinding activity of nsp13 and the Omicron nsp13R392C variant, which is ...
Nicole L Inniss   +2 more
exaly   +3 more sources

N-alkyl and N-benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors [PDF]

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry
COVID-19 pandemic stimulated tremendous efforts to develop therapeutic strategies targeting SARS-CoV-2, leading to the evaluation of a wide range of potential treatments in clinical trials.
Aurora Albano   +18 more
doaj   +2 more sources

LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16 [PDF]

open access: yesPathogens
The emergence of human coronaviruses has led to three epidemics or pandemics in the last two decades, collectively causing millions of deaths and thus highlighting a long-term need to identify new antiviral drug targets and develop antiviral therapeutics.
Yi Ru   +12 more
doaj   +2 more sources

Bat RNA viruses employ viral RHIMs orchestrating species-specific cell death programs linked to Z-RNA sensing and ZBP1-RIPK3 signaling [PDF]

open access: yesiScience
Summary: RHIM is a protein motif facilitating the assembly of large signaling complexes triggering regulated cell death. A few DNA viruses employ viral RHIMs mimicking host RHIMs and counteract cell death by interacting with host RHIM-proteins to ...
Sanchita Mishra   +11 more
doaj   +2 more sources

The Effects of SARS CoV-2 nsp13 Mutations on the Structure and Stability of Helicase in Chinese Isolates

open access: yesEuropean Journal of Biology, 2022
Objective: Coronavirus Disease 2019 (COVID19) is a viral disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2). The high mutation propensity of the SARS CoV-2 genome is one of the biggest threats to the long-term validity of ...
Ekrem Akbulut
doaj   +4 more sources

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists [PDF]

open access: yesEmerging Microbes and Infections, 2020
The Coronavirus disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2 virus, is now causing a tremendous global health concern. Since its first appearance in December 2019, the outbreak has already caused over 5.8 million infections worldwide (
Chun-Kit Yuen   +11 more
doaj   +3 more sources

Assessing SARS-CoV-2 Rare Mutations and Transmission in New York City by NGS [PDF]

open access: yesMicroorganisms
SARS-CoV-2 undergoes frequent mutations that drive viral evolution and genomic diversity, influencing transmissibility, immune escape, and disease severity.
Dakai Liu   +19 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy